Research Highlight | Published:

PROSTATE CANCER

Targeting DLL3 in neuroendocrine prostate cancer

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original article

    1. Puca, L. et al. Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer. Sci. Transl Med. 11, eaav0891 (2019)

    Further reading

    1. Davies, A. H. et al. Cellular plasticity and the neuroendocrine phenotype in prostate cancer. Nat. Rev. Urol. 15, 271–286 (2018)

    Download references

    Author information

    Correspondence to Clemens Thoma.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark